Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ISC Gums is a leading manufacturer and processor of natural hydrocolloids, specializing in the production of high-quality Gum Arabic (Acacia) and other botanical gums. The company serves a diverse range of industries, including pharmaceuticals, nutraceuticals, food, and beverages, providing essential ingredients used as stabilizers, emulsifiers, and coating agents. Based in Edison, New Jersey, ISC Gums operates a state-of-the-art manufacturing facility equipped with advanced spray-drying and purification technologies. The company is recognized for its commitment to quality, offering products that are Non-GMO Project Verified and Certified Organic. In January 2022, ISC Gums was acquired by Nexira, a global leader in natural ingredients, to enhance its North American production capabilities and supply chain. This acquisition allows ISC Gums to leverage Nexira's global reach while maintaining its specialized focus on high-purity natural gum products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ISC Gums.